Latest Commercialisation News

Galilee Energy has finished construction of the Zydeco-1 drilling site in Louisiana, setting the stage for drilling to commence in early July 2026. The well targets a substantial 13.7 billion cubic feet of gas and 610,000 barrels of condensate, underpinning the company’s US Gulf Coast growth ambitions.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.

Pathkey.AI has finalised its takeover of Chipforge, an AI-driven semiconductor design company, issuing shares and performance rights as consideration. The move broadens Pathkey's AI platform capabilities from clinical trials into semiconductor engineering, aiming to shorten chip development cycles significantly.

1414 Degrees has secured $8.45 million in a placement to advance its silicon battery technology and renewable energy projects, targeting drone, defence, space, and data centre markets.

ClearVue Technologies has boosted its capital raising to $6.25 million, with significant board participation and revised loan terms, while its Gen 3 Vision Glass secures crucial EN 1279-5 certification.

EAU Lithium has committed to acquiring Vulcan's proven A-DLE Pilot Plant 4 from Germany, strengthening its capacity to optimise lithium extraction from Bolivian brines and supporting strategic deployment of VULSORB® technology.

CleanSpace's AGILE respirator has achieved AS/NZS 17420.2:2021 certification, paving the way for commercialisation in Australia and New Zealand alongside its recent European approval.

Ore Resources Ltd has revealed new assay results from a 3,300m RC drilling program at its Kangaroo Hills Lithium Project, confirming significant extensions at the Big Red and Potoroo pegmatites and advancing near-term commercialisation options.

Dreadnought Resources has nearly doubled the high-confidence Indicated gold resource at its Metzke’s Find deposit in WA’s Illaara Project, lifting total ounces to about 25,000 at a robust 5.2 g/t grade. The shallow, high-grade resource sits on a granted mining lease and remains open for expansion.

Recce Pharmaceuticals has secured ethics approval to upgrade and broaden its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, accelerating recruitment and reinforcing its global registration ambitions.

Provaris Energy has raised $1 million through a share placement to fund key 2026 development milestones in hydrogen and liquid CO2 storage, reinforcing its technical progress and partnerships.